Related Experiment Video
Updated: Aug 6, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Notch activation promotes bone metastasis via SPARC inhibition in adenoid cystic carcinoma
Ye Zhang1,2,3, Xiaoxiao Liu1,2,3, Lijing Zhu1,2,3
1Department of Oral Pathology, Peking University School and Hospital of Stomatology, Beijing, China.
Objectives:
We aimed to investigate bone metastasis induced by Notch signalling pathway dysregulation and to demonstrate that SPARC is a potential therapeutic target in adenoid cystic carcinoma (AdCC) with Notch dysregulation.
Materials And Methods:
This retrospective study enrolled 144 AdCC patients. RNA-sequencing and enrichment analyses were performed using 32 AdCC samples. Osteonectin/SPARC and the Notch activation indicator Notch intracellular domain (NICD) were detected using immunohistochemistry. Cell proliferation and migration assays were conducted using stably NICD over-expressing cells. The effect of SPARC on osteoclast differentiation in NICD cells was investigated using western blotting, quantitative reverse transcription PCR, tartrate-resistant acid phosphatase staining and resorption assays.
Results:
RNA-sequencing analysis showed that genes down-regulated in Notch-mutant AdCCs, such as SPARC, were enriched in ossification and osteoblast differentiation. Most (75/110, 68.2%) Notch1-wild-type AdCCs showed SPARC over-expression, whereas 30 out of 34 (88.2%) Notch1-mutant tumours showed low SPARC expression. SPARC over-expression was then found negatively to be correlated with NICD expression in 144 AdCCs. NICD over-expression promoted cell growth, migration and osteoclast differentiation, which could be partly reversed by exogenous SPARC.
Conclusions:
Notch activation in AdCC contributes to bone metastasis through SPARC inhibition. The study results suggest that SPARC may represent a prognostic biomarker and potential therapeutic target.
Insights
Notch pathway activation in adenoid cystic carcinoma (AdCC) promotes bone metastasis by inhibiting SPARC. SPARC shows potential as a therapeutic target and prognostic biomarker for AdCC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Adenoid cystic carcinoma (AdCC) is prone to bone metastasis.
- The Notch signaling pathway plays a role in cancer progression.
- SPARC (secreted protein acidic and rich in cysteine) is implicated in bone remodeling.
Purpose of the Study:
- To investigate the role of Notch signaling pathway dysregulation in AdCC bone metastasis.
- To determine if SPARC is a potential therapeutic target in AdCC with Notch dysregulation.
Main Methods:
- Retrospective study of 144 AdCC patients.
- RNA-sequencing and immunohistochemistry on AdCC samples.
- In vitro assays assessing cell proliferation, migration, and osteoclast differentiation in NICD-overexpressing cells.
Main Results:
- Notch pathway activation correlated with down-regulation of SPARC in AdCC.
- Overexpression of Notch intracellular domain (NICD) promoted AdCC cell growth, migration, and osteoclast differentiation.
- Exogenous SPARC partially reversed the pro-metastatic effects of NICD.
Conclusions:
- Notch activation in AdCC contributes to bone metastasis via SPARC inhibition.
- SPARC may serve as a prognostic biomarker for AdCC.
- SPARC represents a potential therapeutic target for AdCC with Notch pathway dysregulation.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
07:26Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Canonical Wnt Signaling Pathway